Key Record Dates
ClinicalTrials.gov Identifier: | NCT04468061 |
---|---|
Brief Title: | Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC |
First Submitted : | July 8, 2020 |
First Submitted that Met QC Criteria : | July 8, 2020 |
First Posted : | July 13, 2020 |
Last Update Submitted that Met QC Criteria : | April 15, 2024 |
Last Update Posted : | April 16, 2024 |